OmniVis is one of the fifty US entrepreneur recipients, representing all US regions across a variety of industries, to win the Alibaba Grants program for US$10,000.

OmniVis published with collaborators at Purdue University and IUSM on malaria detection in patient blood samples.

OmniVis published with collaborators at icddr,b and University of Notre Dame on their 2019 study on device usability.

OmniVis joins the Bay Area Global Health Alliance (BAGHI) in our commitment to equity and innovation in global health. OmniVis is excited to join an alliance with other organizations who are doing groundbreaking work in global health.

OmniVis was one of the winning teams for a $10,000 award to continue work on COVID-19. Thank you to Booz Allen Foundation for this generous award.

OmniVis has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant to conduct research and development (R&D) work on COVID-19 rapid detection technology. 

COVID-19 testing is still not accessible to every individual across the country therefore counties and states across the U.S. must take this into account when considering the effects of reopening businesses. This is where rapid diagnostics technology plays of utmost importance.

Read about how Microsoft is supporting social entrepreneurship startups such as OmniVis in expanding technology for to fuel social innovation at a large scale.

OmniVis’s rapid disease detection technology is funded by the National Science Foundation (NSF) to develop quick and widespread diagnostics for cholera using our platform. With this new funding, we are excited to join the fight against infectious disease from cholera to applications in COVID-19.

OmniVis is facing #COVID-19 with the OmniMask, a 3D printed and personalized face mask engineered in-house. Our goal is to reach communities around the world by providing an affordable and accessible mask alternative.

OmniVisTech is excited to announce that we will be part of Microsoft's Global Social Entrepreneurship program! We cannot wait to work alongside Seabin Project and Zindi Africa to create positive change together.

Last week, Humanitarian Grand Challenge and the World Food Programme hosted an Innovation Week in Munich. OmniVis is proud to have been in attendance and collaborate with other teams.

Thankful to have an honorary mention for the Reach Awards. It's an honor to be recognized in a community of people devoted to ending preventable diseases. #globalhealth #endcholera #diagnosismatters

Clean drinking water is one of the most urgent needs in developing countries and disaster-stricken areas, but safety tests can take days — during which tainted water can infect thousands.

MIT Solve, an initiative of the Massachusetts Institute for Technology, announces the 32 new Solver teams from 16 countries that were selected yesterday at Solve Challenge Finals, the premier live pitch event kicking off UN General Assembly week.

What if you could put a drop of water into a miniature laboratory – not much bigger than a smartphone — and find out if the water contains the bacterium that causes cholera?

There are infinite ways to start a business and infinitely more ways to fail. Every decision can feel overwhelming if you think out every last pro and con, so sometimes you need to trust your gut to move forward. No start-up knows everything, and that’s when it’s important to seek help and mentorship.

We are excited to be participants in The Global Good Fund LEAP program for the next six months.

We are proud to announce that we launched our pilot study in Bangladesh in partnerships with iccddr,b and Notre Dame University’s Global Health Program earlier this month! We sat down for a conversation with Mike Malloy, Halcyon Incubator’s Program Director, to talk about our experience in Dhaka.

We are ecstatic to take home first prize and a sizable check from BioLOGIC! The award will enable us to take a big step forward towards manufacturing at scale, lowering the cost of each device and test.